74,30764,382Additional paid-in capital
71,247,00057,888,506Treasury stock (50,000 shares at cost)
(59,444,151)(51,827,360)Total stockholders' equity
11,852,1566,100,528Total liabilities and stockholders' equity
7,352,245See notes to condensed consolidated financial statementsMiMedx Group, Inc. and SubsidiariesNon-GAAP Financial Measures and ReconciliationAs used herein, "GAAP", refers to generally accepted accounting principles in the United States. We use various numerical measures in conference calls, investor meetings and other forums which are or may be considered "Non-GAAP financial measures" under Regulation G. We have provided below for your reference, supplemental financial disclosure for these measures, including the most directly comparable GAAP measure and an associated reconciliation.
Reconciliation of Net Loss to "Adjusted EBITDA" defined as Earnings before Interest, Taxes, Depreciation, Amortization and Share Based Compensation:ThreeMonths EndedThree Months Ended September 30,Nine Months Ended September 30,June 30, 20112010201120102011Net Loss (Per GAAP)$
(2,503,505)Add back:Income Taxes-----Financing (expense) associated withwarrants issued in connection withconvertible promissory note---(595,679)-Financing (expense) associated withbeneficial conversion of note payableissued in conjunction with acquisition(85,989)-(219,506)-(60,599)Other interest (exp)/inc., net(27,377)(584)(72,145)2,813(26,471)Depreciation Expense98,989114,332330,851337,592115,682Amortization Expense333,977166,9831,001,931500,949333,977Employee Share Based Compensation222,792269,4771,032,261731,216429,096Other Share Based Compensation62,94663,4902
|SOURCE MiMedx Group, Inc.|
Copyright©2010 PR Newswire.
All rights reserved